Product image of Mutaflor (Escherichia Coli Strain Nissle 1917) supplied by GNH India

Mutaflor

Active Ingredient:
Escherichia Coli Strain Nissle 1917
Origin:
EU

Mutaflor (Escherichia Coli Strain Nissle 1917)

Escherichia coli Nissle 1917, the active ingredient in Mutaflor, is a probiotic presented as a 10^9 CFU per capsule for oral use. It is employed to support maintenance of remission in ulcerative colitis and to aid gastrointestinal health in other conditions.
GNH India supplies Mutaflor as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Ardeypharm Gmbh

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Mutaflor is a probiotic that acts on the gastrointestinal microbiota to improve disease outcomes.

  • Ulcerative colitis: helps maintain remission and reduce flare‑ups.
  • Irritable bowel syndrome: may alleviate abdominal discomfort and irregular bowel habits.
  • Antibiotic‑associated diarrhea: assists in preventing diarrhea that can follow broad‑spectrum antibiotic therapy.

How It Works

  • Mutaflor delivers live Escherichia coli Nissle 1917 bacteria that colonize the intestinal lumen, compete with pathogenic microbes for nutrients and adhesion sites, and produce antimicrobial substances. The strain also interacts with gut‑associated lymphoid tissue, modulating local immune responses and promoting a balanced microbial ecosystem that supports intestinal barrier function.

Side Effects

Mutaflor is generally well tolerated, but adverse reactions can occur.

Common Side Effects

  • Bloating: mild abdominal distension reported by some users.
  • Flatulence: increased intestinal gas may be experienced.
  • Nausea: occasional feeling of queasiness.
  • Diarrhea: transient loose stools in the initial treatment period.

Serious or Rare Side Effects

  • Sepsis: rare bloodstream infection, primarily in severely immunocompromised patients.
  • Bacteremia: presence of the probiotic strain in blood, reported in vulnerable individuals.
  • Severe allergic reaction: anaphylaxis or angioedema in hypersensitive patients.
  • Infection of central lines: possible colonisation of indwelling devices in high‑risk settings.

Precautions & Warnings

Before prescribing Mutaflor, clinicians should consider patient‑specific factors and follow safe handling practices.

  • Immune status assessment: evaluate for severe immunosuppression before use.
  • Caution in critical illness: avoid in patients with uncontrolled sepsis or organ failure.
  • Monitor for infection signs: watch for fever, chills, or gastrointestinal bleeding.
  • Concomitant antibiotics: be aware that broad‑spectrum antibiotics may diminish probiotic efficacy.
  • Store at room temperature: keep in the original pack, protect from moisture.

Avoid Interactions

Mutaflor may interact with other agents that alter gut flora or immune function.

Major Interactions (Avoid)

  • Broad‑spectrum antibiotics: can eradicate the probiotic strain, reducing benefit.
  • Immunosuppressants: may increase risk of opportunistic infection.
  • Antifungal agents (e.g., fluconazole): potential alteration of microbial balance.

Moderate Interactions (Monitor Closely)

  • Proton pump inhibitors: altered gastric pH may affect bacterial survival.
  • Non‑steroidal anti‑inflammatory drugs (NSAIDs): may increase gastrointestinal irritation.
  • Live vaccines: probiotic may modulate immune response to vaccination.

Frequently Asked Questions

Mutaflor is a prescription probiotic containing Escherichia coli Nissle 1917. It is used to maintain remission in ulcerative colitis, to help manage symptoms of irritable bowel syndrome, and to prevent diarrhea that can occur after taking broad‑spectrum antibiotics.

The Nissle 1917 strain colonises the intestinal tract, where it competes with harmful bacteria for nutrients and attachment sites. It also produces substances that inhibit pathogens and interacts with gut immune cells, helping to restore a balanced microbiota and support normal intestinal function.

The exact dosing regimen for Mutaflor is determined by the prescribing clinician based on the patient’s condition, age, and overall health. Physicians typically prescribe one capsule containing 10^9 CFU daily, but the final dose and duration should follow the prescriber’s instructions.

Safety data for Mutaflor in pregnancy and lactation are limited, and the product’s pregnancy category is listed as unknown. Healthcare providers should weigh potential benefits against possible risks before prescribing it to pregnant or nursing individuals.

To order Mutaflor, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Mutaflor contains a single, well‑studied strain (E. coli Nissle 1917) with documented efficacy in ulcerative colitis remission, whereas many over‑the‑counter probiotics contain mixed strains with variable evidence. Compared with conventional anti‑inflammatory drugs, Mutaflor offers a microbiota‑focused approach with a different safety profile.

Mutaflor capsules should be stored at room temperature, below 25 °C, in their original packaging. They must be kept away from moisture and direct sunlight to preserve bacterial viability throughout the shelf life.

Mutaflor is taken orally as a capsule. The capsule is swallowed whole with water, usually once daily, unless the prescriber advises a different schedule. It is not intended for sublingual or chewable use.

The most serious risks include rare cases of sepsis or bacteremia, especially in patients with severe immunosuppression, central venous catheters, or critical illness. Anaphylactic reactions, though uncommon, may also occur and require immediate medical attention.

Mutaflor should be avoided in individuals with known hypersensitivity to Escherichia coli Nissle 1917 or any capsule excipients, and in patients who are severely immunocompromised, have uncontrolled sepsis, or possess indwelling medical devices that could be colonised by the probiotic strain.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.